Pregnancy and Birth

 
Preconception CT Scans Tied to Higher Risk of Pregnancy Loss, Congenital Anomalies: Daily Dose
September 29, 2025

Your daily dose of the clinical news you may have missed.

HHS Ties Acetaminophen Use During Pregnancy to Autism, Despite Widely Conflicting Evidence
September 23, 2025

The administration has initiated a nationwide public service campaign about the potential risks as professional societies quickly disputed the claims.

Real-Time Continuous Glucose Monitoring Lowers Risk of Large for Gestational Age Infants in Gestational Diabetes
September 16, 2025

Real-time continuous glucose monitoring significantly enhances glycemic control in gestational diabetes, reducing risks for large newborns compared to traditional methods.

Prior CT Scans Found Linked With Higher Risk of Pregnancy Loss and Birth Defects
September 10, 2025

Although overall risk was just slightly elevated, study authors recommend alternative imaging methods when appropriate for women of childbearing age.

OTC Contraception Option Improves Access For Women at High Risk for Unintended Pregnancy
August 20, 2025

Opill OTC has significantly increased contraceptive use and shifts from less effective options among women who are uninsured, of racial/ethnic minorities, and live in the rural US.

Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update
August 18, 2025

In the RE104 group receiving the 30-mg dose, clinically meaningful reductions in the primary endpoint were seen on day 1 posttreatment and sustained through day 28 follow-up.

New Guidelines Recommend Preconception Screening in Diabetes: Daily Dose
August 04, 2025

Your daily dose of the clinical news you may have missed.

Maternal Depression Found to Disrupt Emotional Responsiveness, Infant Care: Daily Dose
July 31, 2025

Your daily dose of the clinical news you may have missed.

New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism
July 16, 2025

ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.

First Patient Receives Lipocene's LPCN 1154 for Postpartum Depression in Phase 3 Clinical Trial
June 27, 2025

Lipocene anticipates the phase 3 trial data will support an NDA submission for LPCN 1154 to treat PPD in mid-2026, the company said.